DUBLIN--(BUSINESS WIRE)--The "Rheumatology Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global rheumatology therapeutics market to grow with a CAGR of 2.52 % over the period of 2018 - 2024
According to report growing geriatric population and growing prevalence of rheumatic arthritis in the major parts of North America and Europe are likely to drive the growth in the world rheumatic therapeutics market over the forecast period.
The report on rheumatology therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the Global rheumatology therapeutics market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global rheumatology therapeutics market over the period of 2016 - 2024. Further, the author's Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
The global rheumatology therapeutics market s segmented on the basis of drug class, disease indication, and distribution channel
Global Rheumatology Therapeutics Market by Drug Class
- Disease Modifying Anti-rheumatic Drugs
- Nonsteroidal Anti-inflammatory Drugs
- Uric Acid Drugs
Global Rheumatology Therapeutics Market by Disease Indication
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Ankylosing Spondylitis
Global Rheumatology Therapeutics Market by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Rheumatology Therapeutics Market by Regions
- North America
- Takeda Pharmaceutical
- Genentech, Inc.
- Novartis AG
- Janssen Biotech, Inc.
- Amgen, Inc.
- AbbVie, Inc.
- Pfizer, Inc.
- Bristol-Myers Squibb Company
Merck & Co., Inc
For more information about this report visit https://www.researchandmarkets.com/research/n9tbtk/global?w=4